TOP STORIES

• BUSINESS Japan Market Grows in April-June on Hep C Meds, Opdivo: IMS
  August 2, 2016

• BUSINESS Takeda to Revamp R&D Organization, Eyes Consolidated Research Sites in Japan, US
  August 1, 2016

• REGULATORY Pricy Meds Issue Takes a Step Forward with 2-Faceted Proposal
  July 29, 2016

• REGULATORY Chuikyo to Discuss Out-of-Cycle Re-Pricing for Opdivo, but JMA Turns Wary
  July 28, 2016

• BUSINESS Damage Suit Filed over HPV Vaccines; MSD Says Claims Scientifically Unfounded
  July 28, 2016

• REGULATORY MHLW to Canvass Drug Makers’ Opinions on Real-World Roles of “3 Key Officers”: Pharma Safety Head
  July 27, 2016

• REGULATORY ICH Clinical Trial Guidelines Allow Flexibility on Number of Japanese Subjects Needed: PMDA Official
  July 26, 2016

• REGULATORY MRSA Infections Add 190 Billion Yen Annually to Medical Expenditure at DPC Hospitals: MHLW Study Group
  July 25, 2016

• ACADEMIA Japanese Society of Nephrology Aims to Promote Development through “Surrogate Endpoints”; Hopes to Draft Guidelines in FY2017
  July 22, 2016

• REGULATORY PMDA to Announce Evaluation Policy on Diagnosis Using Next-Generation Sequencers
  July 21, 2016

• ACADEMIA New Atherosclerosis Guidelines Likely to Add PCSK9 Inhibitors for Primary Prevention of CAD in Familial Hypercholesterolemia
  July 20, 2016

• REGULATORY CDISC Therapeutic Area Standards “Can Be Used in Japan”: MHLW Study Group
  July 19, 2016

• REGULATORY Generics Should Vie on “Quality and Attractiveness”: MHLW Pharma Bureau Chief
  July 15, 2016

• REGULATORY More Companies Interested in Supporting Academia Research from the Seeds Stage: AMED Official
  July 14, 2016

• REGULATORY MHLW to Set Prerequisites for Patients, Physicians to Optimize Innovative Drug Use: Pharma Bureau Chief
  July 13, 2016

• REGULATORY AMED Aims to Facilitate Drug Makers’ Access to Knowledge at Research Institutions: President
  July 12, 2016

• REGULATORY MHLW to Put Expensive Drug Issue Up for Chuikyo Discussion ASAP: Medical Economics Division Chief
  July 11, 2016

• REGULATORY “New Rules” for Expensive Drugs Could Impact Business Models: Health Insurance Bureau Chief
  July 8, 2016

• BUSINESS Kyorin Anticipates Annual Growth of “at Least 3%” through New Drugs Despite Patent Loss for Kipres: President
  July 7, 2016

• BUSINESS Delving into Securities Filings - 3: Six Companies Report Higher Pay, More Employees
  July 6, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• …
• Next ›
• 最終 »